# FDA recall D-0394-2026

> **New Life Pharma LLC** · Class II · drug recall initiated 2026-02-26.

## Product

Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.

## Reason for recall

Lack of Assurance of Sterility

## Distribution

OH

## Key facts

- **Recall number:** D-0394-2026
- **Recalling firm:** New Life Pharma LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-02-26
- **Report date:** 2026-03-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Northvale, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0394-2026

## Citation

> AI Analytics. FDA recall D-0394-2026. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0394-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*